Pyruvate Dehydrogenase Kinase (AA 350-436), (C-Term) anticorps
Aperçu rapide pour Pyruvate Dehydrogenase Kinase (AA 350-436), (C-Term) anticorps (ABIN363520)
Antigène
Reactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 350-436, C-Term
-
Specificité
- Reacts with the human PDK1
-
Réactivité croisée
- Souris, Poulet, Rat (Rattus)
-
Réactivité croisée (Details)
- Predicted to cross react with mouse (100 % ), rat (100 %), chicken (93 %).
-
Purification
- Purified
-
Immunogène
- Synthetic peptide made to a C-Terminal portion of the human PDK1 protein sequence (between residues 350-436)
-
-
-
-
Indications d'application
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only:
ICC/IF1:1000-1:2000 WB2 μg/mL -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.4 mg/mL
-
Buffer
- Tris-glycine, NaCl 150 mM buffer, Sodium azide 0.05 %
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C/-80 °C
-
Stockage commentaire
- Aliquot and store at -20°C or -80°C. Avoid freeze-thaw cycles.
-
-
- Pyruvate Dehydrogenase Kinase
-
Sujet
- Pyruvate dehydrogenase kinase isoform 1 (PDK1) inhibits the mitochondrial pyruvate dehydrogenase complex by phosphorylation of the E1 alpha subunit, thus contributing to the regulation of glucose metabolism.
-
ID gène
- 5163
Antigène
-